Literature DB >> 22020885

Management of angiotensin-converting enzyme inhibitor-induced angioedema.

Samer Al-Khudari1, Michael J Loochtan, Edward Peterson, Kathleen L Yaremchuk.   

Abstract

OBJECTIVES/HYPOTHESIS: To develop and validate a clinical algorithm for management of patients with angiotensin-converting enzyme inhibitor-induced angioedema (AIIA). STUDY
DESIGN: Prospective cohort observational study.
METHODS: Over 1 year, 40 patients with AIIA were evaluated by otolaryngology, underwent laryngoscopy, and were followed until disease resolution. The need for airway intervention, disposition for appropriate level of care, and other parameters were analyzed.
RESULTS: Treatment started within 61.5 minutes of presentation to the emergency department (ED). Mean duration until resolution of edema was 29 hours. Twenty (50%) patients required intensive care unit (ICU) admission, and six (15%) required intubation. Seventeen (42.5%) were monitored and discharged from the ED. Floor-of-mouth edema was present in 19 (47.5%), and massive tongue edema was found in four (10%) patients. The aryepiglottic fold was involved in 20 (50%) patients on laryngoscopy. Older patients (P = .048) with subjective dyspnea (P = .003) and dysphonia (P = .001) were most likely to require ICU admission. Upper lip swelling had a negative correlation with airway edema identifiable on laryngoscopy alone (P = .008). Dysphonia (n = 16) predicted airway edema upon laryngoscopy (P = .001). All 40 patients were triaged successfully without the need for readmission or escalation of level of care.
CONCLUSIONS: The management protocol was successful in 40 consecutive patients to the appropriate level of care. History and physical examination may predict airway findings identified on laryngoscopy and help guide management when treatment by otolaryngology is not immediately available. A subset of patients will require acute airway intervention and can be identified at initial presentation.
Copyright © 2011 The American Laryngological, Rhinological, and Otological Society, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22020885     DOI: 10.1002/lary.22349

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  10 in total

1.  Angioedema after tPA: what neurointensivists should know.

Authors:  Jennifer E Fugate; Ejaaz A Kalimullah; Eelco F M Wijdicks
Journal:  Neurocrit Care       Date:  2012-06       Impact factor: 3.210

2.  Factors associated with hospitalization of patients with angiotensin-converting enzyme inhibitor-induced angioedema.

Authors:  Cheng Gang; Christopher J Lindsell; Joseph Moellman; Wesley Sublett; Kim Hart; Sean Collins; Jonathan A Bernstein
Journal:  Allergy Asthma Proc       Date:  2013 May-Jun       Impact factor: 2.587

3.  Delayed presentation of ACE inhibitor-induced angio-oedema.

Authors:  Guy Amey; Pasan Waidyasekara; Ramanathan Kollengode
Journal:  BMJ Case Rep       Date:  2013-07-29

4.  A consensus parameter for the evaluation and management of angioedema in the emergency department.

Authors:  Joseph J Moellman; Jonathan A Bernstein; Christopher Lindsell; Aleena Banerji; Paula J Busse; Carlos A Camargo; Sean P Collins; Timothy J Craig; William R Lumry; Richard Nowak; Jesse M Pines; Ali S Raja; Marc Riedl; Michael J Ward; Bruce L Zuraw; Deborah Diercks; Brian Hiestand; Ronna L Campbell; Sandra Schneider; Richard Sinert
Journal:  Acad Emerg Med       Date:  2014-04       Impact factor: 3.451

5.  Management of difficult airway among patients with oropharyngeal angioedema.

Authors:  Vinciya Pandian; Gooi Zhen; Stanola Stanley; Marco Oldsman; Elliott Haut; Lynette Mark; Christina Miller; Alexander Hillel
Journal:  Laryngoscope       Date:  2018-12-26       Impact factor: 3.325

6.  Postanesthetic Severe Oral Angioedema in Patient's Taking Angiotensin-Converting Enzyme Inhibitor.

Authors:  Acílio Marques; Carla Retroz-Marques; Sara Mota; Raquel Cabral; Matos Campos
Journal:  Case Rep Anesthesiol       Date:  2014-11-06

7.  Evaluation of staging criteria for disposition and airway intervention in emergency department angioedema patients.

Authors:  Conor Dass; Maggie Mahaffa; Elizabeth Dang; Ronna Campbell; Zuhair Ballas; Sangil Lee
Journal:  Acute Med Surg       Date:  2021-10-26

8.  The role of serial physical examinations in the management of angioedema involving the head and neck: A prospective observational study.

Authors:  Gary Linkov; Jennifer R Cracchiolo; Norman J Chan; Megan Healy; Nausheen Jamal; Ahmed M S Soliman
Journal:  World J Otorhinolaryngol Head Neck Surg       Date:  2016-02-09

9.  Intraoperative angioedema induced by angiotensin II receptor blocker: a case report.

Authors:  Ala A Alhowary; Haitham Odat; Obada Alali; Ali Al-Omari
Journal:  Patient Saf Surg       Date:  2018-09-20

10.  Fatal outcome of late-onset angiotensin-converting enzyme inhibitor induced angioedema: A case report.

Authors:  Jone Jackeviciute; Vidas Pilvinis; Rugile Pilviniene
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.